Labcorp Holdings Inc. (LH) financial statements: income statement, balance sheet and cash flow
Labcorp Holdings Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Labcorp Holdings Inc. reported revenue of $14.0B (+7.2% year on year) and net income of $877.7M (+17.5% year on year).
Income statement
Labcorp Holdings Inc. income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Revenues
$14.0B
$13.0B
$12.2B
$14.9B
Cost of revenues
$9.9B
$9.4B
$8.8B
$10.5B
Gross profit
$4.0B
$3.6B
$3.4B
$4.4B
Selling, general, and administrative expenses
$2.2B
$2.2B
$2.0B
$2.0B
Amortization of intangibles and other assets
$280.0M
$256.4M
$219.8M
$259.3M
Asset Impairment Charges
$4.3M
$5.3M
—
—
Restructuring and other charges
$127.2M
$46.0M
—
—
Operating income
$1.4B
$1.1B
$725.6M
$1.8B
Interest expense
($224.1M)
($208.3M)
($199.6M)
($180.3M)
Investment income
$15.2M
$22.3M
$28.8M
$8.9M
Equity method loss, net
($13.3M)
($1.4M)
($1.4M)
$5.4M
Other, net
($55.0M)
$60.2M
$15.5M
($25.3M)
Earnings from continuing operations before income taxes
$1.1B
$959.5M
$568.9M
—
Provision for income taxes
$229.8M
$212.4M
$188.5M
$302.0M
Earnings from continuing operations
$877.7M
$747.1M
$380.4M
—
Earnings from discontinued operations, net of tax
$0
$0
$38.8M
—
Net earnings
$877.7M
$747.1M
$419.2M
$1.3B
Less: Net earnings attributable to the noncontrolling interest
($1.2M)
($1.1M)
($1.2M)
($1.5M)
Net earnings attributable to Labcorp Holdings Inc.
$876.5M
$746.0M
$418.0M
$1.3B
Basic earnings per share from continuing operations
$10.54
$8.89
$4.35
—
Basic earnings per share from discontinued operations
$0.00
$0.00
$0.45
—
Basic earnings per share
$10.54
$8.89
$4.80
—
Diluted earnings per share from continuing operations
$10.46
$8.84
$4.33
—
Diluted earnings per share from discontinued operations
$0.00
$0.00
$0.44
—
Diluted earnings per share
$10.46
$8.84
$4.77
—
Labcorp Holdings Inc. income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenues
$3.7B
$3.5B
$3.6B
$3.5B
Cost of revenues
$2.6B
$2.5B
$2.5B
$2.5B
Gross profit
$1.1B
$1.0B
$1.0B
$1.0B
Selling, general, and administrative expenses
$577.2M
$551.0M
$552.4M
$579.3M
Amortization of intangibles and other assets
$78.1M
$75.6M
$69.5M
$68.3M
Restructuring and other charges
$5.1M
$6.4M
$5.9M
$4.1M
Operating income
$451.6M
$380.8M
$396.6M
$394.5M
Interest expense
($61.1M)
($55.1M)
($56.0M)
($57.1M)
Investment income
$5.6M
$12.2M
$3.5M
$1.7M
Equity method loss, net
($6.2M)
($5.1M)
($5.2M)
($1.7M)
Other, net
($3.5M)
($13.1M)
($1.9M)
($32.7M)
Earnings from operations before income taxes
$386.4M
$319.7M
$337.0M
$304.7M
Provision for income taxes
$87.3M
$41.7M
$75.5M
$66.4M
Net earnings
$299.1M
$278.0M
$261.5M
$238.3M
Less: Net earnings attributable to the noncontrolling interest
($400.0K)
($200.0K)
($400.0K)
($400.0K)
Net earnings attributable to Labcorp Holdings Inc.
$298.7M
$277.8M
$261.1M
$237.9M
Basic earnings per share (in dollars per share)
$3.66
$3.37
$3.14
$2.85
Diluted earnings per share (in dollars per share)
$3.64
$3.35
$3.12
$2.84
Balance sheet
Labcorp Holdings Inc. balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$532.3M
$1.5B
$536.8M
$430.0M
Accounts receivable, net
$2.1B
$1.9B
$1.9B
$2.2B
Unbilled services, net
$156.9M
$152.9M
$185.4M
$795.4M
Supplies inventory
$534.7M
$493.2M
$474.6M
$470.6M
Prepaid Expense and Other Assets, Current
$692.8M
—
—
—
Total current assets
$4.0B
$4.8B
$3.8B
$4.6B
Property, plant, and equipment, net
$3.1B
$3.0B
$2.9B
$3.0B
Goodwill, net
$6.8B
$6.4B
$6.1B
$8.1B
Intangible assets, net
$3.6B
$3.5B
$3.3B
$3.9B
Joint venture partnerships and equity method investments
$153.9M
$16.3M
$26.9M
$65.7M
Other assets, net
$751.3M
$652.2M
$536.5M
$432.7M
Total assets
$18.4B
$18.4B
$16.7B
$20.2B
Accounts payable
$840.8M
$875.8M
$827.5M
$934.8M
Accrued expenses and other
$847.8M
$871.2M
$804.0M
$1.1B
Unearned revenue
$439.1M
$392.2M
$421.7M
$582.1M
Short-term operating lease liabilities
$191.1M
$184.6M
$165.8M
$185.5M
Short-term finance lease liabilities
$4.6M
$6.1M
$6.4M
$6.0M
Short-term borrowings and current portion of long-term debt
$500.1M
$1.0B
$999.8M
$301.3M
Total current liabilities
$2.8B
$3.3B
$3.2B
$3.1B
Long-term debt
$5.1B
$5.3B
$4.1B
$5.0B
Operating lease liabilities
$682.6M
$676.3M
$648.9M
$679.7M
Financing lease liabilities
$63.0M
$74.3M
$78.6M
$83.6M
Deferred Income Taxes and Other Tax Liabilities, Noncurrent
$454.5M
—
—
—
Other liabilities
$647.8M
$517.4M
$409.3M
$422.8M
Total liabilities
$9.8B
$10.3B
$8.8B
$10.0B
Noncontrolling interest
$16.9M
$14.3M
$15.5M
$18.9M
Common stock, 82.2 and 83.4 shares outstanding at December 31, 2025, and 2024, respectively
7.5M
7.6M
7.7M
8.1M
Additional paid-in capital
$0
$2.8M
$38.4M
$0
Retained earnings
$8.6B
$8.3B
$7.9B
$10.6B
Accumulated other comprehensive loss
($27.6M)
($261.6M)
($59.3M)
($493.2M)
Total shareholders’ equity
$8.6B
$8.1B
$7.9B
$10.1B
Total liabilities and shareholders’ equity
$18.4B
$18.4B
$16.7B
$20.2B
Labcorp Holdings Inc. balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$141.8M
$981.1M
$598.1M
$647.3M
Accounts receivable, net
$2.3B
$2.3B
$2.1B
$2.1B
Unbilled services, net
$162.4M
$161.9M
$156.1M
$156.1M
Supplies inventory
$562.2M
$497.7M
$521.5M
$508.1M
Prepaid expenses and other
$606.1M
$629.5M
$694.0M
$655.1M
Total current assets
$3.8B
$4.6B
$4.1B
$4.1B
Property, plant, and equipment, net
$3.1B
$3.1B
$3.1B
$3.1B
Goodwill, net
$7.0B
$7.0B
$6.7B
$6.6B
Intangible assets, net
$3.7B
$3.6B
$3.6B
$3.5B
Joint venture partnerships and equity method investments
$139.3M
$146.6M
$168.2M
$160.4M
Other assets, net
$769.3M
$724.9M
$648.1M
$633.0M
Total assets
$18.5B
$19.1B
$18.3B
$18.1B
Accounts payable
$688.5M
$695.7M
$668.5M
$793.0M
Accrued expenses and other
$862.4M
$851.9M
$878.0M
$835.8M
Unearned revenue
$387.8M
$405.2M
$391.6M
$398.0M
Short-term operating lease liabilities
$180.3M
$183.2M
$186.7M
$186.1M
Short-term finance lease liabilities
$4.7M
$4.6M
$4.5M
$4.3M
Short-term borrowings and current portion of long-term debt
$900.0K
$500.4M
$499.9M
$499.6M
Total current liabilities
$2.1B
$2.6B
$2.6B
$2.7B
Long-term debt
$5.9B
$5.8B
$5.1B
$5.1B
Operating lease liabilities
$661.0M
$656.5M
$692.0M
$713.1M
Finance lease liabilities
$61.6M
$62.2M
$64.3M
$65.6M
Deferred income taxes and other tax liabilities
$486.7M
$456.4M
$441.5M
$354.5M
Other liabilities
$717.6M
$691.8M
$639.1M
$643.2M
Total liabilities
$9.9B
$10.3B
$9.5B
$9.6B
Noncontrolling interest
$16.4M
$16.9M
$16.1M
$16.7M
Common stock, 80.9 and 82.2 shares outstanding at June 30, 2026, and December 31, 2025, respectively
7.3M
7.4M
7.5M
7.5M
Additional paid-in capital
$0
$0
$33.0M
$1.8M
Retained earnings
$8.7B
($8.8B)
($8.7B)
($8.5B)
Accumulated other comprehensive loss
($101.9M)
($63.2M)
($42.0M)
($34.6M)
Total shareholders’ equity
$8.6B
$8.7B
$8.7B
$8.5B
Total liabilities and shareholders’ equity
$18.5B
$19.1B
$18.3B
$18.1B
Cash flow statement
Labcorp Holdings Inc. cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net earnings
$877.7M
$747.1M
$419.2M
$1.3B
Earnings from discontinued operations, net of tax
$0
$0
($38.8M)
—
Depreciation and amortization
$681.1M
$643.5M
$577.3M
$633.9M
Stock compensation
$125.8M
$116.7M
$128.7M
$144.1M
Operating lease right-of-use asset expense
$208.1M
$185.3M
—
—
Asset Impairment Charges
$4.3M
$5.3M
—
—
Non-cash portion of Restructuring and other charges
$101.3M
—
—
—
Deferred income taxes
$97.6M
$20.1M
($78.1M)
$18.3M
Other, net
$70.7M
$62.1M
$38.9M
$16.5M
Increase in accounts receivable
($125.5M)
($52.3M)
($103.8M)
$15.9M
Decrease in unbilled services
$3.3M
$30.4M
$28.5M
($100.0M)
Increase in supplies inventory
($30.2M)
($12.6M)
($700.0K)
($45.5M)
Increase in prepaid expenses and other
($25.2M)
($54.5M)
($25.8M)
($256.9M)
(Decrease) increase in accounts payable
($52.8M)
$72.1M
($42.4M)
$307.1M
Increase (decrease) in unearned revenue
$34.6M
($24.6M)
$105.5M
$35.3M
Decrease in accrued expenses and other
($330.3M)
($112.6M)
($323.2M)
($559.3M)
Net cash provided by continuing operating activities
$1.6B
$1.6B
$1.2B
—
Net cash provided by discontinued operating activities
$0
$0
$125.4M
—
Net cash provided by operating activities
$1.6B
$1.6B
$1.3B
$2.0B
Capital expenditures
($434.5M)
($489.9M)
($453.6M)
($481.9M)
Purchase of equity affiliates or other investments
($192.4M)
—
—
—
Proceeds from sale of assets
$8.0M
$2.0M
$600.0K
$1.4M
Proceeds from sale or distribution of equity affiliates or other investments
$6.9M
$0
$6.7M
$5.2M
Proceeds from sale of business
$0
$15.1M
$0
$2.9M
Acquisition of businesses, net of cash acquired
($582.0M)
($839.0M)
($671.5M)
($1.2B)
Net cash used for continuing investing activities
($1.2B)
($1.4B)
($1.1B)
—
Net cash used for discontinued investing activities
$0
$0
($24.7M)
—
Net cash used for investing activities
($1.2B)
($1.4B)
($1.2B)
($1.7B)
Proceeds from senior note offerings
$0
$2.0B
$0
$0
Payments on senior notes
($1.0B)
($1.0B)
($300.0M)
$0
Proceeds from accounts receivable securitization
$225.0M
$300.0M
—
—
Proceeds from revolving credit facilities
$64.8M
$2.5B
$2.5B
$787.4M
Payments on revolving credit facilities
($64.8M)
($2.5B)
($2.5B)
($787.4M)
Net share settlement tax payments from issuance of stock to employees
($31.9M)
($46.4M)
—
—
Net proceeds from issuance of stock to employees
$54.3M
$56.2M
$54.4M
$50.6M
Dividends paid
($240.7M)
($243.1M)
—
—
Purchase of common stock
($450.0M)
($250.1M)
($1.0B)
($1.1B)
Other, net
($13.7M)
($36.7M)
($19.6M)
($27.0M)
Net cash (used for) provided by continuing financing activities
($1.5B)
$779.9M
($1.6B)
—
Net cash provided by discontinued financing activities
$0
$0
$1.5B
—
Net cash (used for) provided by financing activities
($1.5B)
$779.9M
($59.3M)
($1.3B)
Effect of exchange rate changes on cash and cash equivalents
$24.1M
($17.0M)
$9.9M
($24.2M)
Net (decrease) increase in cash and cash equivalents
($986.4M)
$981.9M
$106.8M
($1.0B)
Cash and cash equivalents at beginning of period
$1.5B
$536.8M
—
—
Cash and cash equivalents
$532.3M
$1.5B
$536.8M
—
Labcorp Holdings Inc. cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net earnings
$577.1M
$278.0M
$712.8M
$451.3M
Depreciation and amortization
$352.3M
$173.3M
$508.1M
$337.1M
Stock compensation
$66.6M
$31.7M
$96.1M
$66.9M
Operating lease right-of-use asset expense
$97.1M
$48.0M
$149.1M
$99.4M
Deferred income taxes
$26.4M
$2.0M
$76.4M
($12.2M)
Other, net
$25.6M
$11.4M
$51.7M
$46.1M
Increase in accounts receivable
($247.1M)
($187.9M)
($130.4M)
($139.9M)
(Increase) decrease in unbilled services
($6.9M)
($6.2M)
$3.9M
$4.8M
Increase in supplies inventory
($29.7M)
$35.4M
($17.9M)
($3.5M)
Decrease in prepaid expenses and other
$27.1M
$4.0M
$15.8M
($57.8M)
Decrease in accounts payable
($150.4M)
($138.7M)
($204.4M)
($80.6M)
Decrease in unearned revenue
($49.7M)
($32.1M)
($12.6M)
($8.7M)
Decrease in accrued expenses and other
($51.4M)
($27.4M)
($223.0M)
($179.4M)
Net cash provided by operating activities
$637.0M
$191.5M
$1.0B
$639.1M
Capital expenditures
($252.6M)
($121.0M)
($310.6M)
($203.9M)
Proceeds from sale of assets
$9.7M
$7.8M
$3.5M
$2.4M
Proceeds from sale or distribution of equity affiliates or other investments
$0
—
$6.9M
$6.9M
Purchase of equity affiliates or other investments
($17.5M)
($6.7M)
($179.9M)
$172.0M
Acquisition of businesses, net of cash acquired
($427.9M)
($202.2M)
($324.0M)
($63.5M)
Net cash used for investing activities
($688.3M)
($322.1M)
($804.1M)
($430.1M)
Proceeds from term loan
$750.0M
$750.0M
—
—
Payments on senior notes
($500.0M)
$0
($1.0B)
($1.0B)
Proceeds from revolving credit facilities
$0
$0
$64.8M
$64.8M
Payments on revolving credit facilities
$0
$0
($64.8M)
($64.8M)
Proceeds from accounts receivable securitization
$175.0M
$0
$225.0M
$225.0M
Repayments of Accounts Receivable Securitization
($150.0M)
—
—
—
Net share settlement tax payments from issuance of stock to employees
($46.1M)
($39.8M)
($30.6M)
$29.0M
Net proceeds from issuance of stock to employees
$34.7M
$32.9M
$54.3M
$25.7M
Dividends paid
($119.9M)
($61.2M)
($181.4M)
$121.5M
Purchase of common stock
($451.8M)
($98.0M)
($225.0M)
$200.0M
Other, net
($31.3M)
($3.4M)
($8.9M)
($7.3M)
Net cash used for financing activities
($339.4M)
$580.5M
($1.2B)
($1.1B)
Effect of exchange rate on changes in Cash and cash equivalents